The Californian Institute for Regenerative Medicine (CIRM) today requested the Parkinson’s stem cell therapy project Summit4StemCell to submit a funding request at short notice to the extent of $7.3 million. This is to fund the steps still necessary up to the clinical funds.
If this application were to be approved, tests on humans could begin in around two and a half years.

Here is the report in the San Diego Tribune.

• Prev
• Next